Myriad Genetics Inc (NASDAQ:MYGN)

25.09
Delayed Data
As of 4:00pm ET
 +0.60 / +2.45%
Today’s Change
22.07
Today|||52-Week Range
50.44
-13.69%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 33.00, with a high estimate of 47.00 and a low estimate of 25.00. The median estimate represents a +31.53% increase from the last price of 25.09.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.32
Sales
$202.4M
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -20.84%
 
 
 
 
 
 
Growthannually 8.98%
 
 
 
 
 
 

Sales

Growthquarterly -6.05%
 
 
 
 
 
 
Growthannually 2.51%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.